Challenging the status quo: deprescribing antihypertensive medication in older adults in primary care.
作者信息
Sheppard James P, McManus Richard J
机构信息
Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Brighton and Sussex Medical School, Brighton, UK.
出版信息
Br J Gen Pract. 2024 Oct 31;74(748):484-486. doi: 10.3399/bjgp24X739689. Print 2024 Nov.
Abstract
摘要
相似文献
1
Challenging the status quo: deprescribing antihypertensive medication in older adults in primary care.挑战现状：在基层医疗中减少老年人的降压药物处方
Br J Gen Pract. 2024 Oct 31;74(748):484-486. doi: 10.3399/bjgp24X739689. Print 2024 Nov.
2
Pharmacist-led deprescribing of cardiovascular and diabetes medication within a clinical medication review: the LeMON study (Less Medicines in Older Patients in the Netherlands), a cluster randomized controlled trial.在临床药物审查中由药剂师主导的心血管和糖尿病药物减药：LeMON研究（荷兰老年患者更少用药研究），一项整群随机对照试验。
Int J Clin Pharm. 2025 Jan 23. doi: 10.1007/s11096-025-01863-w.
3
Antihypertensive Deprescribing and Cardiovascular Events Among Long-Term Care Residents.降压药物停用与长期护理居民中心血管事件。
JAMA Netw Open. 2024 Nov 4;7(11):e2446851. doi: 10.1001/jamanetworkopen.2024.46851.
4
The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis.老年人减药对死亡率和健康的可行性及效果：一项系统评价与荟萃分析
Br J Clin Pharmacol. 2016 Sep;82(3):583-623. doi: 10.1111/bcp.12975. Epub 2016 Jun 13.
5
Diabetes Deprescribing in Older Adults: A Randomized Clinical Trial.老年人糖尿病减药：一项随机临床试验。
JAMA Intern Med. 2025 Jun 23. doi: 10.1001/jamainternmed.2025.2015.
6
Preoperative Deprescribing for Medical Optimization of Older Adults Undergoing Surgery: A Systematic Review.术前药物精简用于优化老年手术患者的医疗：系统评价。
J Am Med Dir Assoc. 2022 Apr;23(4):528-536.e2. doi: 10.1016/j.jamda.2021.11.005. Epub 2021 Nov 30.
7
Comparing Fourteen Behavioral Science Electronic Health Record Deprescribing Tools in Older Adults: NUDGE-EHR Adaptive Trial.比较针对老年人的十四种行为科学电子健康记录减药工具：NUDGE-EHR适应性试验
J Am Geriatr Soc. 2025 Jul 4. doi: 10.1111/jgs.19609.
8
Barriers and enablers for deprescribing benzodiazepine receptor agonists in older adults: a systematic review of qualitative and quantitative studies using the theoretical domains framework.老年人群中苯二氮䓬类受体激动剂逐渐停药的障碍和促进因素：应用理论领域框架对定性和定量研究的系统综述。
Implement Sci. 2022 Jul 8;17(1):41. doi: 10.1186/s13012-022-01206-7.
9
Feasibility of a protocol for deprescribing antihypertensive medication in older patients in Dutch general practices.荷兰全科诊所中为老年患者停用降压药物方案的可行性。
BMC Prim Care. 2022 Nov 9;23(1):280. doi: 10.1186/s12875-022-01894-6.
10
Barriers and enablers to deprescribing of older adults and their caregivers: a systematic review and meta-synthesis.老年人及其照护者药物减量的障碍和促进因素：系统评价和元综合。
Eur Geriatr Med. 2023 Dec;14(6):1211-1222. doi: 10.1007/s41999-023-00879-7. Epub 2023 Oct 24.
引用本文的文献
1
Study protocol for developing deprescribing clinical practice guidelines: evidence-based GRADE methodology and a Delphi consensus method.制定减药临床实践指南的研究方案：基于证据的GRADE方法和德尔菲共识法。
BMC Geriatr. 2025 Jul 19;25(1):538. doi: 10.1186/s12877-025-06202-2.
本文引用的文献
1
The effect of deprescribing interventions on mortality and health outcomes in older people: An updated systematic review and meta-analysis.减药干预对老年人死亡率和健康结局的影响：一项更新的系统评价与荟萃分析。
Br J Clin Pharmacol. 2024 Oct;90(10):2409-2482. doi: 10.1111/bcp.16200. Epub 2024 Aug 20.
2
Effect of antihypertensive deprescribing on hospitalisation and mortality: long-term follow-up of the OPTiMISE randomised controlled trial.降压药物停药对住院和死亡的影响：OPTiMISE 随机对照试验的长期随访。
Lancet Healthy Longev. 2024 Aug;5(8):e563-e573. doi: 10.1016/S2666-7568(24)00131-4. Epub 2024 Jul 30.
3
Effects of the discontinuation of antihypertensive treatment on neuropsychiatric symptoms and quality of life in nursing home residents with dementia (DANTON): a multicentre, open-label, blinded-outcome, randomised controlled trial.在养老院患有痴呆的居民中（DANTON）停止抗高血压治疗对神经精神症状和生活质量的影响：一项多中心、开放标签、盲法结局、随机对照试验。
Age Ageing. 2024 Jul 2;53(7). doi: 10.1093/ageing/afae133.
4
The association between antihypertensive treatment and serious adverse events by age and frailty: A cohort study.抗高血压治疗与年龄和虚弱相关的严重不良事件的关联：一项队列研究。
PLoS Med. 2023 Apr 19;20(4):e1004223. doi: 10.1371/journal.pmed.1004223. eCollection 2023 Apr.
5
Treatment and prescribing trends of antihypertensive drugs in 2.7 million UK primary care patients over 31 years: a population-based cohort study.31 年间 270 万英国初级保健患者的降压药治疗和处方趋势：一项基于人群的队列研究。
BMJ Open. 2022 Jun 10;12(6):e057510. doi: 10.1136/bmjopen-2021-057510.
6
Cost-Effectiveness of Antihypertensive Deprescribing in Primary Care: a Markov Modelling Study Using Data From the OPTiMISE Trial.降压药物停药的成本效益：来自 OPTiMISE 试验数据的马克夫模型研究。
Hypertension. 2022 May;79(5):1122-1131. doi: 10.1161/HYPERTENSIONAHA.121.18726. Epub 2022 Mar 10.
7
Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis.降压药物治疗预防心血管疾病和死亡的年龄分层和血压分层效应：一项个体参与者水平数据的荟萃分析。
Lancet. 2021 Sep 18;398(10305):1053-1064. doi: 10.1016/S0140-6736(21)01921-8. Epub 2021 Aug 27.
8
Deprescribing Blood Pressure Treatment in Long-Term Care Residents.在长期护理居民中减少降压治疗。
J Am Med Dir Assoc. 2021 Dec;22(12):2540-2546.e2. doi: 10.1016/j.jamda.2021.07.009. Epub 2021 Aug 6.
9
Association between antihypertensive treatment and adverse events: systematic review and meta-analysis.降压治疗与不良事件的关联：系统评价和荟萃分析。
BMJ. 2021 Feb 10;372:n189. doi: 10.1136/bmj.n189.
10
Withdrawal of antihypertensive drugs in older people.老年人停用抗高血压药物
Cochrane Database Syst Rev. 2020 Jun 10;6(6):CD012572. doi: 10.1002/14651858.CD012572.pub2.
Zotero 插件